Suchergebnisse - "Iwatsuki-Horimoto, Kiyoko"

PubPharm (170)

1

High titers of infectious SARS-CoV-2 in COVID-19 corpses

enthalten in: bioRxiv.org | 2024

von Saitoh, H. | Sakai-Tagawa, Y. | Nagasawa, S. | +35

2

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters

enthalten in: Communications biology | 2024

von Halfmann, P. | Iwatsuki-Horimoto, K. | Kuroda, M. | +16

3

Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan

enthalten in: Epidemiology and infection | 2024

von Yamayoshi, S. | Nagai, E. | Mitamura, K. | +11

4

Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Maruki, T. | Nomoto, H. | Iwamoto, N. | +7

5

Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV

enthalten in: BMC microbiology | 2024

von Ishizaka, A. | Koga, M. | Mizutani, T. | +6

6

Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV

enthalten in: BMC microbiology | 2024

von Ishizaka, A. | Koga, M. | Mizutani, T. | +6

7

An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants

enthalten in: NPJ vaccines | 2024

von Uraki, R. | Imai, M. | Ito, M. | +7

8

Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Hagihara, M. | Hayashi, H. | Nakashima, S. | +10

9

Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo

enthalten in: Cell reports | 2023

von Uraki, R. | Kiso, M. | Iwatsuki-Horimoto, K. | +17

10

Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan

enthalten in: One health (Amsterdam, Netherlands) | 2023

von Yamayoshi, S. | Ito, M. | Iwatsuki-Horimoto, K. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]